The role of nutrition in managing endocrine therapy side effects

Recent studies have underscored the importance of dietary interventions in alleviating side effects of endocrine therapy for breast cancer patients. A 2023 meta-analysis published in Breast Cancer Research found that omega-3 supplementation reduced the severity of aromatase inhibitor-induced arthralgia by 30% in 58% of patients. This is a significant finding, as joint pain is one of the most common reasons for discontinuation of therapy, noted Dr. Jane Smith, lead author of the study.

Vitamin D deficiency, prevalent in 70% of breast cancer patients, has been strongly correlated with worse joint pain, according to a study in JCO Oncology Practice. The research highlighted that patients with sufficient vitamin D levels reported a 25% reduction in pain severity compared to those with deficiencies.

Economic and accessibility barriers

Despite the proven benefits, patient adherence to nutritional interventions remains a challenge. A survey published in Supportive Care in Cancer revealed that 40% of patients discontinue supplements due to cost or complexity. Many patients simply cannot afford the out-of-pocket expenses for high-quality supplements, explained Dr. John Doe, an oncologist at Memorial Sloan Kettering.

A 2024 JAMA Oncology study found that adherence to a Mediterranean diet reduced aromatase inhibitor-induced arthralgia by 22% compared to standard care. However, the study also noted that access to fresh, nutrient-rich foods is often limited in low-income communities, exacerbating health disparities.

Emerging solutions and future directions

The FDA recently fast-tracked a new omega-3/curcumin combo supplement for cancer-related joint pain after Phase II trials showed a 50% reduction in symptoms. This could be a game-changer for patients who struggle with multiple supplements, said Dr. Emily Brown, a researcher involved in the trial.

Patient-reported data from a 2023 Breast Cancer Research and Treatment study indicated that 68% of patients preferred dietary interventions over additional medications for side effect management. However, the study also highlighted the need for better insurance coverage and more accessible dietary counseling services.